Int J Cardiol. 2019 Jan 05. pii: S0167-5273(18)34315-8. [Epub ahead of print]
Atsuko Imai-Okazaki,
Yoshihito Kishita,
Masakazu Kohda,
Yosuke Mizuno,
Takuya Fushimi,
Ayako Matsunaga,
Yukiko Yatsuka,
Tomoko Hirata,
Hiroko Harashima,
Atsuhito Takeda,
Akihiro Nakaya,
Yasushi Sakata,
Shigetoyo Kogaki,
Akira Ohtake,
Kei Murayama,
Yasushi Okazaki.
BACKGROUND: Cardiomyopathy is a reported indicator of poor prognosis in children with mitochondrial disease. However, the association between prognosis and the genetic background of cardiomyopathy in children with mitochondrial disease has yet to be fully elucidated.
METHODS AND RESULTS: Of 137 children with mitochondrial disease whose genetic diagnosis was made between 2004 and 2018, 29 had mitochondrial cardiomyopathy (21%). After a median follow-up of 35 months, the overall survival rate was significantly lower in patients with cardiomyopathy than in those without (p < 0.001). Ten-year Kaplan-Meier estimates of overall survival were 18 and 67%, respectively. Among the 21 cardiomyopathy patients who died, two died within one month of birth (COQ4 in one patient, and COX10 in one patient), ten died within one year (BOLA3 in three patients, QRSL1 in two patients, large chromosomal deletions in two patients, MT-ATP6/8 in one patient, MT-TL1 in one patient, and TAZ gene in one patient), and nine died after one year (MT-ND5 in three patients, MT-TL1 in three patients, ACAD9 in one patient, KARS in one patient, and MT-TV in one patient). In the three patients with mitochondrial DNA mutations whose cardiac tissues were available, high heteroplasmy rates in the cardiac tissue were observed for m.8528T>C (90%, died at 2 months of age) and m.3243A>G (90 and 80%, died at 12 and 13 years of age, respectively).
CONCLUSIONS: In children with mitochondrial disease, cardiomyopathy was common (21%) and was associated with increased mortality. Genetic analysis coupled with detailed phenotyping could be useful for prognosis.
Keywords: Exome sequencing; Infantile cardiomyopathy; Mitochondrial cardiomyopathy; Mitochondrial disease; Mitochondrial respiratory chain complex deficiencies